Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei

Annals of Surgical Oncology

Volumn 17, Issue 5, 2010, Pages 1291-1301

  Saxena, Akshat ^a   Yan, Tristan D ^a   Chua, Terence C ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; FLUOROURACIL; METRONIDAZOLE; MITOMYCIN C;

ADULT; ARTICLE; CLINICAL ASSESSMENT; COLON RESECTION; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; ILEOSTOMY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; OPERATION DURATION; PERIOPERATIVE PERIOD; PERITONEUM PSEUDOMYXOMA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RISK ASSESSMENT; RISK FACTOR; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL TECHNIQUE; UNIVARIATE ANALYSIS;

ADENOCARCINOMA, MUCINOUS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PERIOPERATIVE CARE; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PSEUDOMYXOMA PERITONEI; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77952098890     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0875-9     Document Type: Article

References (36)

1. PH Sugarbaker 1994 Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon Ann Surg 219 109 111 1:STN:280:DyaK2c7nsFKgsg%3D%3D 8129480
2. M Deraco D Baratti M Inglese B Allaria S Andreola C Gavazzi, et al. 2004 Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): A strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei Ann Surg Oncol 11 393 398 10.1245/ASO.2004.07.002 15070599 (Pubitemid 40486749)
3. P Piso H Bektas U Werner HJ Schlitt S Kubicka A Bornscheuer, et al. 2001 Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma Eur J Surg Oncol 27 286 290 10.1053/ejso.2000.1095 1:STN:280:DC%2BD3M3ptVWlsw%3D%3D 11373107 (Pubitemid 32621755)
4. RM Smeenk VJ Verwaal N Antonini FA Zoetmulder 2007 Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Ann Surg 245 104 109 10.1097/01.sla.0000231705.40081.1a 17197972 (Pubitemid 46035441)
5. D Elias C Honore R Ciuchendea V Billard B Raynard R Lo Dico, et al. 2008 Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Br J Surg 95 1164 1171 10.1002/bjs.6235 1:STN:280:DC%2BD1crhs12ntA%3D%3D 18690633
6. S Gonzalez-Moreno PH Sugarbaker 2004 Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding Br J Surg 91 304 311 10.1002/bjs.4393 1:STN:280: DC%2BD2c7gtVSmsw%3D%3D 14991630 (Pubitemid 38375769)
7. Yan TD, Black D, Savady R, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2007;14:484-92. (Pubitemid 46175292)
8. O Glehen F Kwiatkowski PH Sugarbaker D Elias EA Levine M De Simone, et al. 2004 Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study J Clin Oncol 22 3284 3292 10.1200/JCO.2004.10.012 1:STN:280:DC%2BD2cvgs1Giuw%3D%3D 15310771 (Pubitemid 41103684)
9. J Hansson W Graf L Pahlman P Nygren H Mahteme 2009 Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy Eur J Surg Oncol 35 202 208 1:STN:280:DC%2BD1M%2Fns1KksQ%3D%3D 18514475
10. VJ Verwaal H van Tinteren SV Ruth FA Zoetmulder 2004 Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy J Surg Oncol 85 61 67 10.1002/jso.20013 14755505 (Pubitemid 38160772)
11. D Elias D Goere F Blot V Billard M Pocard N Kohneh-Shahri, et al. 2007 Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43°C after compete cytoreductive surgery: Mortality and morbidity in 106 consecutive patients Ann Surg Oncol 14 1818 1824 10.1245/s10434-007-9348-1 17356950 (Pubitemid 46870938)
12. RM Smeenk VJ Verwaal FA Zoetmulder 2006 Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei-a report of 103 procedures Eur J Surg Oncol 32 186 190 10.1016/j.ejso.2005.08.009 1:STN:280:DC%2BD287gtlCjtw%3D%3D 16303281 (Pubitemid 43257121)
13. S Kusamura R Younan D Baratti P Costanzo M Favaro C Gavazzi, et al. 2006 Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: Analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique Cancer 106 1144 1153 10.1002/cncr.21708 16456817 (Pubitemid 43297355)
14. AD Stephens R Alderman D Chang GD Edwards J Esquivel G Sebbag, et al. 1999 Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique Ann Surg Oncol 6 790 796 10.1007/s10434-999-0790-0 1:STN:280:DC%2BD3c%2Fos1ahsw%3D%3D 10622509 (Pubitemid 30013658)
15. O Glehen D Osinsky E Cotte F Kwiatkowski G Freyer S Isaac, et al. 2003 Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: Morbidity and mortality analysis of 216 consecutive procedures Ann Surg Oncol 10 863 869 10.1245/ASO.2003.01.018 1:STN:280:DC%2BD3svmsFGhug%3D%3D 14527903 (Pubitemid 40486849)
16. TD Yan M Links S Fransi T Jacques D Black V Saunders, et al. 2007 Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy-a journey to becoming a Nationally Funded Peritonectomy Center Ann Surg Oncol 14 2270 2280 10.1245/s10434-007-9406-8 17464543 (Pubitemid 47174916)
17. TD Yan G Edwards R Alderman CE Marquardt PH Sugarbaker 2007 Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma-a prospective study of 70 consecutive cases Ann Surg Oncol 14 515 525 10.1245/s10434-006-9187-5 17031722 (Pubitemid 46175296)
18. P Jacquet AD Stephens AM Averbach D Chang SE Ettinghausen RR Dalton, et al. 1996 Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy Cancer 77 2622 2629 10.1002/(SICI)1097- 0142(19960615)77:12<2622::AID-CNCR28>3.0.CO;2-T 1:STN:280: DyaK283jvFeltg%3D%3D 8640714 (Pubitemid 26169161)
19. Z Guner U Schmidt MH Dahlke HJ Schlitt J Klempnauer P Piso 2005 Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei Int J Colorectal Dis 20 155 160 10.1007/s00384-004-0648-7 1:STN:280:DC%2BD2M%2FlvVKitg%3D%3D 15503065 (Pubitemid 40227522)
20. N Gusani S Cho C Colovos S Seo J Franko S Richard, et al. 2008 Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center Ann Surg Oncol 15 754 763 10.1245/s10434-007-9701-4 18080166
21. P Jacquet PH Sugarbaker 1996 Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis Cancer Treat Res 82 359 374 1:STN:280:DyaK2s%2Fgt1Kitw%3D%3D 8849962 (Pubitemid 26130826)
22. ASA 1963 New classification of physical status Anesthesiology 24 111 114
23. PH Sugarbaker 1995 Peritonectomy procedures Ann Surg 221 29 42 1:STN:280:DyaK2M7is1OhsQ%3D%3D 7826158
24. BM Ronnett H Yan RJ Kurman BM Shmookler L Wu PH Sugarbaker 2001 Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis Cancer 92 85 91 10.1002/1097-0142(20010701) 92:1<85::AID-CNCR1295>3.0.CO;2-R 1:STN:280:DC%2BD3MzovVyisQ%3D%3D 11443613 (Pubitemid 32623044)
25. TJ Miner J Shia DP Jaques DS Klimstra MF Brennan DG Coit 2005 Long-term survival following treatment of pseudomyxoma peritonei: An analysis of surgical therapy Ann Surg 241 300 308 10.1097/01.sla.0000152015.76731.1f 15650641
26. DB Gough JH Donohue AJ Schutt N Gonchoroff JR Goellner TO Wilson, et al. 1994 Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach Ann Surg 219 112 119 10.1097/00000658-199402000-00002 1:STN:280:DyaK2c7nsFKgsw%3D%3D 8129481 (Pubitemid 24064067)
27. S Al-Homoud S Purkayastha O Aziz JJ Smith MD Thompson AW Darzi, et al. 2004 Evaluating operative risk in colorectal cancer surgery: ASA and POSSUM-based predictive models Surg Oncol 13 83 92 10.1016/j.suronc.2004.08.006 15572090 (Pubitemid 39572082)
28. P McCulloch J Ward PP Tekkis 2003 Mortality and morbidity in gastro-oesophageal cancer surgery: Initial results of ASCOT multicentre prospective cohort study BMJ 327 1192 1197 10.1136/bmj.327.7425.1192 14630753 (Pubitemid 37465202)
29. RA Schroeder CE Marroquin BP Bute S Khuri WG Henderson PC Kuo 2006 Predictive indices of morbidity and mortality after liver resection Ann Surg 243 373 379 10.1097/01.sla.0000201483.95911.08 16495703 (Pubitemid 43327770)
30. EC Vamvakas 2002 Possible mechanisms of allogeneic blood transfusion-associated postoperative infection Transfus Med Rev 16 144 160 10.1053/tmrv.2002.31463 11941576
31. GE Hill WH Frawley KE Griffith JE Forestner JP Minei 2003 Allogeneic blood transfusion increases the risk of postoperative bacterial infection: A meta-analysis J Trauma 54 908 914 10.1097/01.TA.0000022460.21283.53 12777903 (Pubitemid 36758801)
32. Saxena A, Yan TD, Morris DL. Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures. Eur J Surg Oncol. 2009 [Epub ahead of print].
33. R Loungnarath S Causeret N Bossard M Faheez AC Sayag-Beaujard, et al. 2005 Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: A prospective study Dis Colon Rectum 48 1372 1379 10.1007/s10350-005-0045-5 15909071 (Pubitemid 40933864)
34. RM Smeenk VJ Verwaal FA Zoetmulder 2007 Learning curve of combined modality treatment in peritoneal surface disease Br J Surg 94 1408 1414 10.1002/bjs.5863 1:CAS:528:DC%2BD2sXhsVGitbbO 17631678 (Pubitemid 350144391)
35. TC Chua TD Yan ME Smigielski KJ Zhu KM Ng J Zhao, et al. 2009 Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution Ann Surg Oncol 16 1903 1911 10.1245/s10434-009-0341-8 19387742
36. S Kusamura D Baratti R Younan B Laterza G Oliva P Costanzo, et al. 2007 Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity Ann Surg Oncol 14 2550 2558 10.1245/s10434-007-9429-1 17558537 (Pubitemid 47393524)